|
|
||||||||
MUCOSAL BIOLOGY
Departamento de Biología and Cell Dynamics and Biotechnology Research Center, Facultad de Ciencias, Universidad de Chile, Santiago, Chile
Submitted 9 March 2007 ; accepted in final form 23 October 2007
Hepcidin (Hepc) is considered a key mediator in iron trafficking. Although the mechanism of Hepc action in macrophages is fairly well established, much less is known about its action in intestinal cells, one of the main targets of Hepc. The current study investigated the effects of physiologically generated Hepc on iron transport in Caco-2 cell monolayers and rat duodenal segments compared with the effects on the J774 macrophage cell line. Addition of Hepc to Caco-2 cells or rat duodenal segments strongly inhibited apical 55Fe uptake without apparent effects on the transfer of 55Fe from the cells to the basolateral medium. Concurrently, the levels of divalent metal transporter 1 (DMT1) mRNA and protein in Caco-2 cells decreased while the mRNA and protein levels of the iron export transporter ferroportin did not change. Plasma membrane localization of ferroportin was studied by selective biotinylation of apical and basolateral membrane domains; Hepc induced rapid internalization of ferroportin in J774 cells but not in Caco-2 cells These results indicate that the effect of Hepc is cell dependent: in macrophages it inhibits iron export by inducing ferroportin degradation, whereas in enterocytes it inhibits apical iron uptake by inhibiting DMT1 transcription. Our results highlight the crucial role of Hepc in the control of intestinal iron absorption.
intestinal iron absorption; divalent metal transporter 1; ferroportin
This article has been cited by other articles:
![]() |
M. B Zimmermann, B. Troesch, R. Biebinger, I. Egli, C. Zeder, and R. F Hurrell Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1280 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chung, T. Chaston, J. Marks, S. K. Srai, and P. A. Sharp Hepcidin Decreases Iron Transporter Expression in Vivo in Mouse Duodenum and Spleen and in Vitro in THP-1 Macrophages and Intestinal Caco-2 Cells J. Nutr., August 1, 2009; 139(8): 1457 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Peslova, J. Petrak, K. Kuzelova, I. Hrdy, P. Halada, P. W. Kuchel, S. Soe-Lin, P. Ponka, R. Sutak, E. Becker, et al. Hepcidin, the hormone of iron metabolism, is bound specifically to {alpha}-2-macroglobulin in blood Blood, June 11, 2009; 113(24): 6225 - 6236. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Theurl, E. Aigner, M. Theurl, M. Nairz, M. Seifert, A. Schroll, T. Sonnweber, L. Eberwein, D. R. Witcher, A. T. Murphy, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood, May 21, 2009; 113(21): 5277 - 5286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Roe, R. Collings, J. R Dainty, D. W Swinkels, and S. J Fairweather-Tait Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1088 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Karl, H. R. Lieberman, S. J. Cable, K. W. Williams, E. L. Glickman, A. J. Young, and J. P. McClung Poor Iron Status Is Not Associated with Overweight or Overfat in Non-Obese Pre-Menopausal Women J. Am. Coll. Nutr., February 1, 2009; 28(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |